Peking Union Medical College Hospital: clinical-trial pipeline
Peking Union Medical College Hospital is the sponsor of 1,148 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 337 are not yet finished and 16 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials337
Phase 2/3 and 365
Countries2
New in 90 days16
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 652 |
| Phase 2 | 181 |
| Phase 4 | 107 |
| Early phase 1 | 73 |
| Phase 1/2 | 44 |
| Phase 3 | 36 |
| Phase 2/3 | 29 |
| Phase 1 | 26 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 595 |
| Recruiting | 201 |
| Completed | 197 |
| Not yet recruiting | 107 |
| Active, not recruiting | 29 |
| Withdrawn or not authorised | 8 |
| Terminated | 7 |
| Suspended or halted | 4 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 442 |
| Gastroenterology and liver | 122 |
| Women's health and obstetrics | 100 |
| Cardiovascular | 99 |
| Metabolic and endocrine (diabetes, obesity) | 95 |
| Immunology and rheumatology | 77 |
| Rare and genetic diseases | 72 |
| Nephrology and urology | 71 |
| Respiratory | 64 |
| Infectious disease and vaccines | 57 |
| Haematology | 46 |
| Neurology | 39 |
Countries
| Country | Trials |
|---|---|
| China | 986 |
| United States | 2 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-23 | New trial posted | Oxaliplatin-Based Adjuvant Therapy for Gastrointestinal Neuroendocrine Carcinoma** |
| 2026-10-21 | New trial posted | Perfusion Efficiency-Guided MAP De-escalation in Elderly Septic Shock |
| 2026-10-16 | New trial posted | Multi-omics Study of Cervical Neuroendocrine Carcinoma |
| 2026-10-16 | New trial posted | Tripterygium Wilfordii Plus Prednisone for Active IgG4-Related Disease |
| 2026-10-16 | New trial posted | Extension Study of the PUMCH-E101 Clinical Trial：Safety and Efficacy Study of PUMCH-E101… |
| 2026-10-16 | New trial posted | FAPI PET Imaging in Nonischemic Cardiomyopathy |
| 2026-10-15 | New trial posted | 40 Hz Gamma Auditory Stimulation for Delirium Prevention in Critically Ill ICU Patients |
| 2026-09-23 | New trial posted | 68Ga-NYM215 in NENs |
| 2026-09-23 | New trial posted | [18F]FIDT-10b PET Imaging in Cardiac Amyloidosis |
| 2026-09-23 | New trial posted | Lenvatinib Plus Chemotherapy for pNET Liver Metastases |
| 2026-09-21 | New trial posted | Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA |
| 2026-09-16 | New trial posted | Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Rel… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT03023371 | National Registry of IgG4-RD in China | Not applicable | Recruiting | China |
| NCT06499974 | POASAC Study (Preoperative Anemia Severity and Classification Study) | Not applicable | Recruiting | China |
| NCT05643703 | Cesarean Section Defect Mechanism and Transvaginal Repair | Not applicable | Not yet recruiting | |
| NCT06557928 | Protocol for Evaluating Physiological and Psychological Adaptation Mechanisms in Tibetan Plateau Environments | Not applicable | Recruiting | China |
| NCT07704177 | Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Lo… | Phase 2 | Recruiting | China |
| NCT06023784 | The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricula… | Not applicable | Recruiting | China |
| NCT05559645 | Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EG… | Not applicable | Recruiting | China |
| NCT06963008 | A Prospective, Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA) in Chinese Adults With Cystic Fi… | Early phase 1 | Active, not recruiting | China |
| NCT07101237 | An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Charac… | Not applicable | Recruiting | China |
| NCT07065175 | KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal Injury | Phase 2 | Not yet recruiting | China |
| NCT07381569 | To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion | Not applicable | Not yet recruiting | China |
| NCT06861543 | The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherap… | Phase 1 | Recruiting | China |
| NCT07691801 | Study on the Application of Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Aldostero… | Not applicable | Recruiting | China |
| NCT05751018 | Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-s… | Phase 2 | Recruiting | China |
| NCT04650243 | Clinical Research of Tapering UDCA in PBC Patients With a Complete Response | Phase 4 | Recruiting | China |
| NCT05804916 | Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer | Phase 2/3 | Recruiting | China |
| NCT07065942 | Effects of Lactulose on Gut Microbiota and Metabolism in Diabetic Constipated Patients | Not applicable | Recruiting | China |
| NCT05289245 | A National Registry on Chinese Patients With Cystic Fibrosis | Not applicable | Recruiting | China |
| NCT06362304 | 99mTc-CNDG SPECT/CT in Brain Tumors | Not applicable | Recruiting | China |
| NCT06660329 | Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome | Phase 4 | Recruiting | China |
| NCT05842746 | Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma | Phase 2 | Not yet recruiting | China |
| NCT06070740 | First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Car… | Phase 2 | Recruiting | China |
| NCT07473271 | Vaginal Function Exercisers and Vaginal Dilation Irrigation Drug Administration Tubes Are Used for Vaginal Re… | Not applicable | Recruiting | China |
| NCT07653659 | Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pressure in Distributive Shock | Not applicable | Recruiting | China |
| NCT06534281 | Pilot Study of BAO-G Technique in TAAA Endovascular Repair | Early phase 1 | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Peking Union Medical College Hospital clinical trials: 337 open, 65 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/peking-union-medical-college-hospital/, data as of 2026-10-25.